학술논문
A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC).
Document Type
Journal
Author
Spigel, David R.; Reckamp, Karen L.; Rizvi, Naiyer A.; Poddubskaya, Elena; West, Howard Jack; Eberhardt, Wilfried Ernst Erich; Baas, Paul; Antonia, Scott Joseph; Pluzanski, Adam; Vokes, Everett E.; Holgado, Esther; Waterhouse, David Michael; Ready, Neal; Gainor, Justin F.; Aren, Osvaldo Rudy; Horn, Leora; Paz-Ares, Luis; Baudelet, Christine; Lestini, Brian Joseph; Brahmer, Julie R.
Source
Subject
Language
English
ISSN
15277755